483
Taisho Pharmaceutical Co., Ltd.Taisho Pharmaceutical Co., Ltd. – FDA 483, Mar 25, 2019
Record Details
An inspection of Taisho Pharmaceutical Co., Ltd. in Saitama, Japan, revealed significant deficiencies across its operations. The firm was cited for inadequate laboratory and production controls, including issues with data integrity, validation, and system security. Additionally, batch production and control records were found to be incomplete, and written calibration procedures for instruments and temperature monitoring were deficient.
View Company Profile
ID · a775bef3-32f7-4fea-9bc0-366c3688398a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.